CD44 and breast carcinoma: CD24 was found to be significantly increased in the ZEB1sh-ET cells, correlating with increased CD24 receptor expression, as determined by FACS (data not shown), consistent with our previous findings that EMT traits in human breast cancer cell lines correlate with the CD44(hi/+)/CD24(lo/-) stem-cell signature [12,73].